All Company news Press releases January 13, 2022September 13, 2024 ENPICOM secures Series B funding to scale up operations to meet the high demand for its antibody discovery SaaS Platform
All Company news Press releases October 7, 2021September 13, 2024 ENPICOM participates in Inno4vac, a European new public-private partnership to innovate vaccine development
All Company news Press releases September 7, 2021October 25, 2024 ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
All Company news August 25, 2021September 14, 2024 ENPICOM is featured among the top 50 fastest growing Data Science SMEs in the Netherlands
All Company news Press releases June 10, 2021October 25, 2024 ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford
All Industry insights June 8, 2021September 13, 2024 Empowering research teams: The path to accessible immune repertoire data
All Company news Press releases May 27, 2021October 16, 2024 Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows
All Industry insights May 6, 2021October 25, 2024 The impact of high-throughput immune repertoire sequencing on the analysis of antibody responses: A conversation with Prof. Gunilla Karlsson Hedestam of Karolinska Institute
All Industry insights April 7, 2021October 25, 2024 Breaking the UX barrier: Towards user-focused biomedical software
ENPICOM
Svitlana Lozova 
ENPICOM Team 